Original Article| Volume 62, ISSUE 6, P658-668, September 15, 2007

Tumor Necrosis Factor-α and Its Inducer Inhibit Morphine-Induced Rewarding Effects and Sensitization


      Tumor necrosis factor-α (TNF-α) is emerging as an important modulator of the function of the central nervous system (CNS). We have demonstrated that TNF-α or Leu-Ile, a TNF-α inducer, inhibits methamphetamine-induced rewarding effects and sensitization. In this study, we investigated the effects of TNF-α or Leu-Ile on morphine (MOR)-induced rewarding effects and sensitization.


      Levels of TNF-α messenger RNA (mRNA) and protein were determined by real-time reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry. Effects of TNF-α or Leu-Ile on MOR-induced rewarding effects and sensitization were investigated by conditioned place preference and locomotor activity tests. Extracellular dopamine levels were examined using in vivo microdialysis. Effects of TNF-α or Leu-Ile on MOR-induced antinociceptive effect and withdrawal symptoms were examined by hot plate test and naloxone-preciptated withdrawal.


      Morphine induced TNF-α mRNA expression via dopamine and opioid receptors. Posttreatment with TNF-α or Leu-Ile attenuated the MOR-induced place preference and sensitization even after their development, as well as pretreatment with TNF-α or Leu-Ile blocked them. An inhibitory effect of Leu-Ile on MOR-induced place preference was not observed in TNF-α knockout mice. Tumor necrosis factor-α or Leu-Ile inhibited the increase in extracellular dopamine levels in the nucleus accumbens induced by repeated MOR treatment.


      These results suggest that TNF-α inhibits MOR-induced rewarding effect and sensitization by regulating extracellular dopamine levels, and Leu-Ile inhibits them via the induction of TNF-α.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Albensi B.C.
        • Mattson M.P.
        Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity.
        Synapse. 2000; 35: 151-159
        • Aloe L.
        • Fiore M.
        TNF-α expressed in the brain of transgenic mice lowers central tyrosine hydroxylase immunoreactivity and alters grooming behavior.
        Neurosci Lett. 1997; 238: 65-68
        • Beattie E.C.
        • Stellwagen D.
        • Morishita W.
        • Bresnahan J.C.
        • Ha B.K.
        • Von Zastrow M.
        • et al.
        Control of synaptic strength by glial TNF alpha.
        Science. 2002; 295: 2282-2285
        • Bluthe R.M.
        • Pawlowski M.
        • Suarez S.
        • Parnet P.
        • Pittman Q.
        • Kelley K.W.
        • et al.
        Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice.
        Psychoneuroendocrinology. 1994; 19: 197-207
        • Bonci A.
        • Williams J.T.
        Increased probability of GABA release during withdrawal from morphine.
        J Neurosci. 1997; 17: 796-803
        • Boudreau A.C.
        • Wolf M.E.
        Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens.
        J Neurosci. 2005; 25: 9144-9151
        • Brase D.A.
        • Loh H.H.
        • Way E.L.
        Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains.
        J Pharmacol Exp Ther. 1977; 201: 368-374
        • Cen X.
        • Nitta A.
        • Ohya S.
        • Zhao Y.
        • Ozawa N.
        • Mouri A.
        • et al.
        An analogue of dipeptide-like structure of FK506 increases GDNF expression through CREB activated by Hsp90/Akt signaling pathway.
        J Neurosci. 2006; 26: 3335-3344
        • Chavkin C.
        • Goldstein A.
        Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus.
        Proc Natl Acad Sci U S A. 1984; 81: 7253-7257
        • Di Chiara G.
        • North R.A.
        Neurobiology of opioid abuse.
        Trends Pharmacol Sci. 1992; 13: 185-193
        • Everitt B.J.
        • Wolf M.E.
        Psychomotor stimulant addiction: A neural systems perspective.
        J Neurosci. 2002; 22: 3312-3320
        • Franklin K.B.J.
        • Paxinos G.
        The Mouse Brain in Stereotaxic Coordinates.
        Academic press, San Diego1997
        • Funada M.
        • Suzuki T.
        • Narita M.
        • Misawa M.
        • Nagase H.
        Blockade of morphine reward through the activation of κ-opioid receptors in mice.
        Neuropharmacology. 1993; 32: 1315-1323
        • Giros B.
        • Jaber M.
        • Jones S.R.
        • Wightman R.M.
        • Caron M.G.
        Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.
        Nature. 1996; 379: 606-612
        • Guha M.
        • Bai W.
        • Nadler J.L.
        • Natarajan R.
        Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways.
        J Biol Chem. 2000; 275: 17728-17739
        • Hamdy M.M.
        • Noda Y.
        • Miyazaki M.
        • Mamiya T.
        • Nozaki A.
        • Nitta A.
        • et al.
        Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: An association with cortical Ca2+/calmodulin-dependent signal cascade.
        Behav Brain Res. 2004; 152: 263-270
        • Heikkila R.E.
        • Orlansky H.
        • Cohen G.
        Studies on the distinction between uptake inhibition and release of 3H-dopamine in rat brain tissue slices.
        Biochem Pharmacol. 1975; 24: 847-852
        • Itoh A.
        • Shiotani T.
        • Nakayama S.
        • Mamiya T.
        • Hasegawa T.
        • Noda Y.
        • et al.
        Attenuation of the development of morphine dependence/tolerance by nefiracetam: Involvement of adenosine 3’:5’-cyclic monophosphate system.
        Behav Brain Res. 2000; 115: 65-74
        • Johnson S.M.
        • Fleming W.W.
        Mechanisms of cellular adaptive sensitivity changes: Applications to opioid tolerance and dependence.
        Pharmacol Rev. 1989; 41: 435-488
        • Johnson S.W.
        • North R.A.
        Opioids excite dopamine neurons by hyperpolarization of local interneurons.
        J Neurosci. 1992; 12: 483-488
        • Kalivas P.W.
        • Stewart J.
        Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity.
        Brain Res Brain Res Rev. 1991; 16: 223-244
        • Koob G.F.
        Drugs of abuse: Anatomy, pharmacology and function of reward pathways.
        Trends Pharmacol Sci. 1992; 13: 177-184
        • Koob G.F.
        • Nestler E.J.
        The neurobiology of drug addiction.
        J Neuropsychiatry Clin Neurosci. 1997; 9: 482-497
        • Koob G.F.
        • Sanna P.P.
        • Bloom F.E.
        Neuroscience of addiction.
        Neuron. 1998; 21: 467-476
        • Kuwahara M.
        • Sugimoto M.
        • Tsuji S.
        • Miyata S.
        • Yoshida A.
        Cytosolic calcium changes in a process of platelet adhesion and cohesion on a von Willebrand factor-coated surface under flow conditions.
        Blood. 1999; 94: 1149-1155
        • Laakso A.
        • Mohn A.R.
        • Gainetdinov R.R.
        • Caron M.G.
        Experimental genetic approaches to addiction.
        Neuron. 2002; 36: 213-228
        • Law P.Y.
        • Hom D.S.
        • Loh H.H.
        Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment.
        Mol Pharmacol. 1982; 22: 1-4
        • Maier S.F.
        • Watkins L.R.
        Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition.
        Psychol Rev. 1998; 105: 83-107
        • Mamiya T.
        • Noda Y.
        • Ren X.
        • Hamdy M.
        • Furukawa S.
        • Kameyama T.
        • et al.
        Involvement of cyclic AMP systems in morphine physical dependence in mice: Prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
        Br J Pharmacol. 2001; 132: 1111-1117
        • Matthews R.T.
        • German D.C.
        Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine.
        Neuroscience. 1984; 11: 617-625
        • Messer C.J.
        • Eisch A.J.
        • Carlezon Jr, W.A.
        • Whisler K.
        • Shen L.
        • Wolf D.H.
        • et al.
        Role for GDNF in biochemical and behavioral adaptations to drugs of abuse.
        Neuron. 2000; 26: 247-257
        • Miyamoto Y.
        • Yamada K.
        • Nagai T.
        • Mori H.
        • Mishina M.
        • Furukawa H.
        • et al.
        Behavioral adaptations to addictive drugs in mice lacking the NMDA receptor ϵ1 subunit.
        Eur J Neurosci. 2004; 19: 151-158
        • Mizoguchi H.
        • Yamada K.
        • Mizuno M.
        • Mizuno T.
        • Nitta A.
        • Noda Y.
        • et al.
        Regulations of methamphetamine reward by extracellular signal-regulated kinase 1/2/ets-like gene-1 signaling pathway via the activation of dopamine receptors.
        Mol Pharmacol. 2004; 65: 1293-1301
        • Nagai T.
        • Kamei H.
        • Ito M.
        • Hashimoto K.
        • Takuma K.
        • Nabeshima T.
        • et al.
        Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and hyperlocomotion, but not anti-nociceptive effect in mice.
        J Neurochem. 2005; 93: 1272-1279
        • Nagai T.
        • Noda Y.
        • Ishikawa K.
        • Miyamoto Y.
        • Yoshimura M.
        • Ito M.
        • et al.
        The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
        J Neurochem. 2005; 92: 660-667
        • Nagai T.
        • Yamada K.
        • Yoshimura M.
        • Ishikawa K.
        • Miyamoto Y.
        • Hashimoto K.
        • et al.
        The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release.
        Proc Natl Acad Sci U S A. 2004; 101: 3650-3655
        • Nakajima A.
        • Yamada K.
        • Nagai T.
        • Uchiyama T.
        • Miyamoto Y.
        • Mamiya T.
        • et al.
        Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity.
        J Neurosci. 2004; 24: 2212-2225
        • Narita M.
        • Funada M.
        • Suzuki T.
        Regulations of opioid dependence by opioid receptor types.
        Pharmacol Ther. 2001; 89: 1-15
        • Nestler E.J.
        Molecular basis of long-term plasticity underlying addiction.
        Nat Rev Neurosci. 2001; 2: 119-128
        • Nestler E.J.
        From neurobiology to treatment: Progress against addiction.
        Nat Neurosci. 2002; 5: 1076-1079
        • Nitta A.
        • Nishioka H.
        • Fukumitsu H.
        • Furukawa Y.
        • Sugiura H.
        • Shen L.
        • et al.
        Hydrophobic dipeptide Leu-Ile protects against neuronal death by inducing brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis.
        J Neurosci Res. 2004; 78: 250-258
      1. Niwa M, Nitta A, Yamada Y, Nakajima A, Saito K, Seishima M, et al (in press): An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-α protects methamphetamine-induced reward and sensitization. Biol Psychiatry.

        • Noda Y.
        • Miyamoto Y.
        • Mamiya T.
        • Kamei H.
        • Furukawa H.
        • Nabeshima T.
        Involvement of dopaminergic system in phencyclidine-induced place preference in mice pretreated with phencyclidine repeatedly.
        J Pharmacol Exp Ther. 1998; 286: 44-51
        • Oliverio A.
        • Castellano C.
        • Eleftheriou B.E.
        Morphine sensitivity and tolerance: A genetic investigation in the mouse.
        Psychopharmacologia. 1975; 42: 219-224
        • Puttfarcken P.S.
        • Werling L.L.
        • Cox B.M.
        Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: A useful model for the study of tolerance at μ opioid receptors.
        Mol Pharmacol. 1988; 33: 520-527
        • Rahman I.
        • MacNee W.
        Regulation of redox glutathione levels and gene transcription in lung inflammation: Therapeutic approaches.
        Free Radic Biol Med. 2000; 28: 1405-1420
        • Ren X.
        • Noda Y.
        • Mamiya T.
        • Nagai T.
        • Nabeshima T.
        A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
        Behav Brain Res. 2004; 152: 243-250
        • Robinson T.E.
        • Berridge K.C.
        The psychology and neurobiology of addiction: An incentive-sensitization view.
        Addiction. 2000; 95: S91-S117
        • Seiden L.S.
        • Sabol K.E.
        • Ricaurte G.A.
        Amphetamine: Effects on catecholamine systems and behavior.
        Annu Rev Pharmacol Toxicol. 1993; 33: 639-677
        • Taniguchi T.
        • Tanaka M.
        • Ikeda A.
        • Momotani E.
        • Sekikawa K.
        Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor α deficient mice.
        Lab Invest. 1997; 77: 647-658
        • Terwilliger R.Z.
        • Beitner-Johnson D.
        • Sevarino K.A.
        • Crain S.M.
        • Nestler E.J.
        A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function.
        Brain Res. 1991; 548: 100-110
        • Tsuji S.
        • Sugimoto M.
        • Miyata S.
        • Kuwahara M.
        • Kinoshita S.
        • Yoshioka A.
        Real-time analysis of mural thrombus formation in various platelet aggregation disorders: Distinct shear-dependent roles of platelet receptors and adhesive proteins under flow.
        Blood. 1999; 94: 968-975
        • Vassali P.
        The pathophysiology of tumor necrosis factors.
        Annu Rev Immunol. 1992; 10: 411-452
        • Vezina P.
        • Stewart J.
        Conditioning and place-specific sensitization of increases in activity induced by morphine in VTA.
        Phamacol Biochem Behav. 1984; 20: 925-934
        • Wada R.
        • Tifft C.J.
        • Proia R.L.
        Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation.
        Proc Natl Acad Sci U S A. 2000; 97: 10954-10959
        • Wise R.A.
        Neurobiology of addiction.
        Curr Opin Neurobiol. 1996; 6: 243-251
        • Yamada K.
        • Iida R.
        • Miyamoto Y.
        • Saito K.
        • Sekikawa K.
        • Sedishima M.
        • et al.
        Neurobehavioral alternations in mice with a targeted deletion of the tumor necrosis factor-alpha gene: Implication for emotional behavior.
        J Neuroimmunol. 2000; 111: 131-138
        • Yamada K.
        • Nagai T.
        • Nabeshima T.
        Drug dependence, synaptic plasticity, and tissue plasminogen activator.
        J Pharmacol Sci. 2005; 97: 157-161

      Linked Article

      • Erratum
        Biological PsychiatryVol. 69Issue 6
        • Preview
          An error has been discovered in “Tumor Necrosis Factor-α and Its Inducer Inhibit Morphine-Induced Rewarding Effects and Sensitization” by Niwa et al., which appeared in Biological Psychiatry (2007;62:658–668).
        • Full-Text
        • PDF